By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856



Company News
Omeros Corporation (OMER) Suspends Enrollment In Huntington's Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday 10/21/2014 5:41:25 AM
Omeros Corporation (OMER) Reports Second Quarter 2014 Financial Results 8/12/2014 8:39:47 AM
Omeros Corporation (OMER) To Present At The Wedbush Pacgrow 2014 Life Sciences Management Access Conference 8/8/2014 8:40:36 AM
Omeros Corporation (OMER) Receives FDA Approval Of Omidria™ For Use In Cataract And Other Intraocular Lens Replacement Procedures 6/2/2014 6:49:25 AM
Omeros Corporation (OMER) Reports First Quarter 2014 Financial Results 5/13/2014 6:26:46 AM
Omeros Corporation (OMER) To Present At The 13th Annual Needham Healthcare Conference 4/7/2014 6:38:10 AM
Omeros Corporation (OMER) Release: Investigational New Drug Application Cleared By FDA For OMS721 In Thrombotic Microangiopathies 4/3/2014 9:27:31 AM
Omeros Corporation (OMER) Invited To Present On OMS824 Phase 2 Clinical Program At The Schizophrenia International Research Conference 4/1/2014 6:39:14 AM
Omeros Corporation (OMER) To Present At Biocentury Future Leaders In The Biotech Industry Conference 3/21/2014 6:22:19 AM
Omeros Corporation (OMER) Closes $40.25 Million Public Offering Of Common Stock 3/20/2014 6:57:38 AM